What Is NAMPT? The Enzyme That Recycles NAD+ Inside Your Cells

Most conversations about nicotinamide adenine dinucleotide, commonly known as NAD+, focus on the molecule itself: its role in cellular energy, its decline with age, and the precursors used to raise it. Far fewer explain the enzyme quietly responsible for making most of that recycling possible in the first place.

That enzyme is nicotinamide phosphoribosyltransferase, or NAMPT, and it plays what researchers describe as the rate-limiting role in the NAD+ salvage pathway, the primary route by which most tissues regenerate their NAD+ supply on an ongoing basis (Sun et al., 2025). Understanding NAMPT is genuinely useful, not just academically interesting, because it explains why NAD+ metabolism responds the way it does to age, exercise, sleep and specific nutrients, information that rarely makes it into simplified explanations of the NAD+ pathway.

What Is NAMPT, Exactly?

NAMPT is an enzyme first identified in immune B cells, where it was originally named pre-B cell colony-enhancing factor, or PBEF, for its role in B cell maturation (Su et al., 2024). It was independently rediscovered years later and named visfatin, after researchers found it was secreted by visceral fat tissue and appeared to have insulin-like effects (Su et al., 2024).

These overlapping discoveries reflect just how many different biological systems NAMPT touches: immune function, metabolic signalling and, most centrally for longevity science, NAD+ biosynthesis.

Why Is NAMPT Called "Rate-Limiting"?

In biochemistry, a rate-limiting enzyme is the slowest, most tightly regulated step in a multi-step pathway, effectively setting the pace for the entire process. NAMPT holds this position within the NAD+ salvage pathway (Chini et al., 2024).

Specifically, NAMPT catalyses the conversion of nicotinamide (NAM), a by-product generated whenever NAD+ is consumed by enzymes such as sirtuins, PARPs or CD38, into nicotinamide mononucleotide (NMN), the direct precursor from which NAD+ is synthesised in the pathway's final step (Su et al., 2024). Because this conversion step, NAM to NMN, is the slowest part of the entire salvage cycle, the amount of active NAMPT available effectively determines how quickly a cell can regenerate its NAD+ supply.

Think of NAMPT as a recycling depot. NAD+ is broken down constantly as cells go about their normal metabolic work, but instead of being wasted entirely, its nicotinamide by-product is funnelled back through NAMPT and rebuilt into fresh NAD+, provided the depot itself is working at capacity.

How Does NAMPT Fit Into the Bigger NAD+ Picture?

NAMPT is one piece of a three-pathway system the body uses to maintain NAD+ levels: the de novo pathway, which builds NAD+ from the amino acid tryptophan; the Preiss-Handler pathway, which uses nicotinic acid; and the salvage pathway, which recycles nicotinamide via NAMPT (Chini et al., 2024).

Of these three, the salvage pathway is considered the dominant route for maintaining NAD+ in most adult tissues, since nicotinamide is continuously regenerated as a by-product of ordinary NAD+ consumption, making NAMPT activity a particularly influential variable in day-to-day NAD+ metabolism (Su et al., 2024). This is also why understanding NAMPT complements, rather than replaces, understanding what consumes NAD+ in the first place, since supply and consumption operate as two sides of the same system.

Does NAMPT Decline with Age?

Yes. Research consistently shows that NAMPT levels decrease during ageing, occurring alongside a parallel decline in sirtuin activity, while CD38, the primary NAD+-degrading enzyme, tends to increase over the same period (Chini et al., 2024).

This combination is significant: falling NAMPT means the salvage pathway becomes less efficient at regenerating NAD+, while rising CD38 activity simultaneously increases how quickly NAD+ is broken down, creating a pattern in which both supply and demand move in the wrong direction at once. Direct evidence of this has been documented in skeletal muscle specifically, where age-associated decreases in NAMPT have been measured directly in human and animal tissue (Su et al., 2024).

NAMPT in Skeletal Muscle: A Particularly Important Case

Skeletal muscle is one of the tissues most closely studied in relation to NAMPT, given its high energy demand and its central role in age-related physical decline.

A 2024 review examining the NAMPT-driven salvage pathway in skeletal muscle found that this pathway plays a critical role in sustaining NAD+ levels specifically in high-energy tissues, and that declining NAMPT activity is implicated not only in ageing muscle but also in conditions such as type 2 diabetes and muscle injury (Su et al., 2024). The same review highlighted that both exercise and NAD+ precursor supplementation represent viable strategies for supporting the NAMPT-driven salvage pathway, offering a plausible mechanistic explanation for why physical activity has repeatedly been shown to help preserve NAD+ metabolism in ageing muscle.

NAMPT and the Body Clock: A Circadian Connection

One of the more fascinating aspects of NAMPT biology is its tight relationship with the body's internal circadian clock, the roughly 24-hour cycle governing sleep, metabolism and hormone release.

Research shows that NAMPT-dependent NAD+ biosynthesis operates in a tissue-specific, circadian manner, meaning NAMPT activity, and therefore NAD+ regeneration, naturally rises and falls at different times of day depending on the tissue involved (Chini et al., 2024). Separate research has demonstrated that the time of day at which NAD+ precursors are administered can influence their efficacy in treating diet-induced metabolic disease in animal models by synchronising the hepatic circadian clock (Chini et al., 2024).

This circadian dimension helps explain why consistent sleep patterns are increasingly recognised as relevant to NAD+ metabolism, since disrupted circadian rhythms may interfere with the natural, time-dependent regulation of NAMPT activity.

Is There More Than One Form of NAMPT?

Yes, and the distinction matters. NAMPT exists in two forms: an intracellular form (iNAMPT) that performs the enzymatic conversion of NAM to NMN inside the cell, and a secreted, extracellular form (eNAMPT) that circulates in the bloodstream (Su et al., 2024).

Extracellular NAMPT has been studied for its involvement in inflammatory signalling and metabolic regulation beyond the cell in which it originated, and its circulating levels have been investigated as a potential biomarker in several metabolic and age-related conditions, an active area of ongoing research (Su et al., 2024).

Can NAMPT Activity Be Supported?

Because NAMPT sits at the rate-limiting step of NAD+ regeneration, researchers have explored several approaches aimed at supporting its activity or working around it.

Exercise has been directly linked to improved NAMPT-driven salvage pathway function in skeletal muscle, offering one of the most consistently evidence-backed, non-pharmacological strategies available (Su et al., 2024). Because NAD+ precursors such as nicotinamide riboside enter the salvage pathway downstream of NAMPT's rate-limiting step, supplementing with NR or NMN is another studied approach, effectively supplying the pathway with substrate closer to where NAD+ is ultimately synthesised, which may be particularly relevant when NAMPT activity itself has declined with age (Su et al., 2024). This is the underlying rationale explored in more detail on Longevita's science page, which outlines how each formulation ingredient maps onto specific points in cellular ageing biology.

Supporting Healthy Ageing

Because NAMPT activity is influenced by exercise, circadian rhythm and overall metabolic health, supporting the NAD+ salvage pathway works best as part of a broader, lifestyle-integrated strategy rather than a single intervention.

Regular exercise has been shown to support the skeletal muscle NAD+ salvage pathway specifically, while consistent sleep patterns may help preserve the circadian regulation that governs NAMPT activity throughout the day (Su et al., 2024; Chini et al., 2024).

Supplements may provide additional support, but they work best as part of a broader, multi-pathway approach addressing NAD+ synthesis, mitochondrial function and inflammation together.

How Longevita™ Supports the NAD+ Salvage Pathway

The research summarised here highlights why the salvage pathway, and NAMPT's role within it, matters so directly to cellular ageing: as NAMPT activity naturally declines with age, supplying the pathway with precursor substrates downstream of this rate-limiting step becomes an increasingly relevant strategy for maintaining NAD+ regeneration.

This is the scientific rationale behind The Longevita™ Supplement, a doctor-formulated, 12-ingredient longevity formula designed to target the key hallmarks of ageing by promoting cellular energy, helping manage senescent cell burden, and strengthening antioxidant and inflammation defence systems.

At its core, Longevita™ combines Nicotinamide Riboside Chloride, which boosts NAD⁺ levels to activate sirtuins and enhance DNA repair, with Nicotinamide, which sustains NAD⁺ pools for mitochondrial energy and antioxidant defence, both entering the salvage pathway at points that reduce reliance on NAMPT's own declining activity. Alongside these precursors, Coenzyme Q10 preserves mitochondrial ATP production and reduces oxidative stress, while Calcium Alpha Ketoglutarate enhances mitochondrial energy and reduces inflammaging via epigenetic modulation.

To support the broader cellular systems influenced by NAD+ availability, Longevita™ includes Trans-Resveratrol, which activates SIRT1 for mitochondrial function while promoting autophagy and DNA repair, and Pterostilbene, which activates SIRT1/AMPK pathways to enhance mitochondrial biogenesis with superior bioavailability. Fisetin supports the clearance of senescent cells, Piperine upregulates antioxidant enzymes and enhances mitochondrial biogenesis via PGC-1α, and Ginseng activates antioxidant pathways and promotes autophagy via SIRT1 and FOXO signalling. L-Theanine, Lutein and Hyaluronic Acid extend the formula's support to cognition, visual health and skin.

Formulated by a doctor and longevity specialist, and manufactured in a GMP-certified, USFDA-registered facility with third-party testing for potency and contaminants, Longevita™ is built on the premise, detailed further on our ingredients page, that supporting NAD+ status requires addressing the salvage pathway directly, not assuming NAMPT activity alone will keep pace with age-related demand.

The Bottom Line

NAMPT is the rate-limiting enzyme responsible for recycling nicotinamide back into usable NAD+ through the salvage pathway, the primary route most tissues rely on to maintain their NAD+ supply. Its activity declines measurably with age, particularly in high-energy tissues like skeletal muscle, while operating on its own tissue-specific circadian rhythm that links NAD+ metabolism to sleep and daily biological timing.

Understanding NAMPT's role clarifies why NAD+ metabolism responds the way it does to exercise, sleep and supplementation, and reinforces why a comprehensive, multi-pathway approach to supporting NAD+ synthesis remains more aligned with the underlying biology than focusing on NAD+ levels alone.

Explore The Longevita™ Supplement, a doctor-formulated, 12-ingredient longevity formula designed to support NAD+ status, mitochondrial function and cellular resilience as part of a daily routine.

FAQs

1. What does NAMPT do in the body?

NAMPT is the rate-limiting enzyme in the NAD+ salvage pathway, converting nicotinamide, a by-product of NAD+ consumption, into nicotinamide mononucleotide (NMN), the direct precursor used to resynthesise NAD+.

2. Does NAMPT decline with age?

Yes. Research shows NAMPT levels decrease during ageing, occurring alongside declining sirtuin activity and rising CD38 activity, a combination that reduces NAD+ regeneration while increasing its breakdown.

3. Can exercise improve NAMPT activity?

Yes. Research on skeletal muscle specifically shows that exercise supports the NAMPT-driven NAD+ salvage pathway, offering one of the most consistently evidence-backed, non-pharmacological ways to support NAD+ regeneration.

4. What is the difference between intracellular and extracellular NAMPT?

Intracellular NAMPT (iNAMPT) performs the enzymatic conversion within cells, while extracellular NAMPT (eNAMPT) is a secreted form that circulates in the bloodstream and has been studied for its role in inflammatory and metabolic signalling.

References

Chini, C.C.S. et al. (2024) 'NAD metabolism: role in senescence regulation and aging', Aging Cell, 23(10), e13920.

Su, M., Qiu, F., Li, Y., Che, T., Li, N. & Zhang, S. (2024) 'Mechanisms of the NAD+ salvage pathway in enhancing skeletal muscle function', Frontiers in Cell and Developmental Biology, 12, 1464815.

Sun, J.Y., Wang, Z.F., Xu, W.H. & Zhao, J. (2025) 'NAD+ glycohydrolases-CD38 as a therapeutic target in ageing: physiological roles, molecular mechanisms, and future opportunities in anti-ageing research', Biochemical and Biophysical Research Communications, in press.

Zhang, L. et al. (2025) 'Nicotinamide phosphoribosyltransferase in NAD+ metabolism: physiological and pathophysiological implications', Cell Death Discovery, 11, 371.